OUR STORY

 

The World Immunotherapy Congress is a commercially focused event that focuses on the discovery, development, commercialisation and marketing of immunotherapies.

Based in the life science hub of Basel, the critical industry gathering looks at commercialising and pushing forward the entire developmental pipelines of these therapies, as well as focusing on the hottest new individual therapeutics. 

Launched last year, the World Immunotherapy Congress successfully brought together some of the top researchers working in big pharma, academia and biotech to talk about some of the hottest trends and therapeutics for 2016.

2017 will be looking at pushing the limits on cutting edge research and trials for one of the hottest therapeutics around. 

KEY THEMES FOR 2017 INCLUDE:

  • Immune checkpoint inhibitors
  • Cell therapy
  • Combination therapy
  • Novel discovery and biomarkers